+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoprecipitation Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies), Product Type (Agarose Beads, Magnetic Beads), End User, Application - Global Forecast 2025-2030- Product Image
Immunoprecipitation Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies), Product Type (Agarose Beads, Magnetic Beads), End User, Application - Global Forecast 2025-2030- Product Image
Sale

Immunoprecipitation Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies), Product Type (Agarose Beads, Magnetic Beads), End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533317
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunoprecipitation market is experiencing robust expansion, powered by advances in antibody technology, automation, and integrated analytics. Senior decision-makers need clear, actionable intelligence to leverage evolving opportunities, address operational challenges, and stay ahead in a dynamic research landscape.

Market Snapshot: Immunoprecipitation Market Overview

The Immunoprecipitation Market grew from USD 1.64 billion in 2024 to USD 2.00 billion in 2025. It is expected to continue growing at a CAGR of 20.90%, reaching USD 5.14 billion by 2030. This sustained momentum reflects both technological advancements and the rising demand for high-precision analysis across multiple scientific and clinical domains. The market’s strong trajectory supports increased investment, enhanced industry collaboration, and rapid adoption of innovation across research and development environments.

Scope & Segmentation

This report examines the immunoprecipitation market in detail, outlining key segments and target audiences to ensure practical, strategic value for decision-makers:

  • Antibody Types: Monoclonal antibodies (including mouse and rabbit) for specificity-driven applications, and polyclonal antibodies (goat, rabbit) for broader epitope recognition.
  • Product Types: Agarose beads for traditional workflows and magnetic beads (paramagnetic, superparamagnetic) for automation compatibility and rapid separation needs.
  • End Users: Academic and research institutes, contract research organizations, and pharmaceutical and biotechnology companies, all with differing requirements from fundamental discovery to scalable development.
  • Applications: Epigenetics, post-translational modification study, and protein analysis, suited for diverse experimental objectives.
  • Regional Coverage: Americas (including United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and more).
  • Key Companies: Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., Abcam plc, Bio-Techne Corporation, QIAGEN N.V., Becton, Dickinson and Company, PerkinElmer, Inc., GenScript Biotech Corporation.

Key Takeaways for Senior Leaders

  • Innovations in antibody design and bead technologies are enabling significantly greater specificity, sensitivity, and reproducibility for immunoprecipitation workflows.
  • Automation integration is reducing manual workload, enhancing data quality, and scaling throughput, making advanced proteomics and epigenetic studies increasingly feasible for a wider range of organizations.
  • End-user requirements are dictating the development of modular, adaptable kits and solutions, supporting both high-throughput screening and specialized research goals.
  • Regional market dynamics vary: North American leadership stems from institutional collaboration and investment in automation, while Asia-Pacific is rapidly growing due to expanded R&D infrastructure and government support.
  • Supplier strategies are shifting towards domestic production, inventory management, and partnership with regulatory authorities to ensure reliable access to critical reagents and supplies.

Tariff Impact on Supply and Sourcing

Recent United States tariff adjustments on imported antibodies, beads, and reagents have disrupted global supply chains, raising procurement costs and complicating laboratory logistics. In response, companies are diversifying sourcing strategies, investing in regional manufacturing, and enhancing inventory practices to reduce vulnerability and maintain continuity of research activities. Collaboration with regulators supports streamlined customs clearance, building resilience despite trade uncertainty.

Methodology & Data Sources

Findings in this report are built on a comprehensive research methodology. Secondary research included peer-reviewed publications, patents, technical documents, and regulatory data. These were supported by structured interviews with industry scientists, R&D executives, and contract research leaders. Insights were validated by quantitative adoption checks and advisory panel review, ensuring accuracy and relevance.

Why This Report Matters to Decision-Makers

  • Provides actionable strategic guidance for navigating operational and supply chain complexities in immunoprecipitation research.
  • Delivers clear segmentation and regional insights, allowing leaders to prioritize investments, partnerships, and technology adoption relevant to their organizational goals.
  • Supports proactive decision-making by offering up-to-date perspectives on technology integration and evolving market needs.

Conclusion

Immunoprecipitation technologies are becoming foundational in modern research, driven by innovation, adaptation to global trade changes, and tailored product development for evolving scientific requirements. This report equips leaders with critical intelligence to support sustainable growth and strategic advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of automated immunoprecipitation platforms to increase throughput and reproducibility
5.2. Development of specialized magnetic bead formulations for high specificity protein capture in complex samples
5.3. Advancements in crosslinking chemistries to improve transient protein interaction stabilization during immunoprecipitation
5.4. Emergence of dual-affinity purification tags enabling simultaneous immunoprecipitation and protein quantification
5.5. Rise of high-resolution mass spectrometry integration with immunoprecipitation workflows for proteome profiling
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunoprecipitation Market, by Antibody
8.1. Introduction
8.2. Monoclonal Antibodies
8.2.1. Mouse Monoclonal
8.2.2. Rabbit Monoclonal
8.3. Polyclonal Antibodies
8.3.1. Goat Polyclonal
8.3.2. Rabbit Polyclonal
9. Immunoprecipitation Market, by Product Type
9.1. Introduction
9.2. Agarose Beads
9.3. Magnetic Beads
9.3.1. Paramagnetic Beads
9.3.2. Superparamagnetic Beads
10. Immunoprecipitation Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical And Biotechnology Companies
11. Immunoprecipitation Market, by Application
11.1. Introduction
11.2. Epigenetics
11.3. Post Translational Modification Study
11.4. Protein Analysis
12. Americas Immunoprecipitation Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Immunoprecipitation Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Immunoprecipitation Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Danaher Corporation
15.3.4. Bio-Rad Laboratories, Inc.
15.3.5. Abcam plc
15.3.6. Bio-Techne Corporation
15.3.7. QIAGEN N.V.
15.3.8. Becton, Dickinson and Company
15.3.9. PerkinElmer, Inc.
15.3.10. GenScript Biotech Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. IMMUNOPRECIPITATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. IMMUNOPRECIPITATION MARKET: RESEARCHAI
FIGURE 24. IMMUNOPRECIPITATION MARKET: RESEARCHSTATISTICS
FIGURE 25. IMMUNOPRECIPITATION MARKET: RESEARCHCONTACTS
FIGURE 26. IMMUNOPRECIPITATION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMMUNOPRECIPITATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MOUSE MONOCLONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MOUSE MONOCLONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY RABBIT MONOCLONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY RABBIT MONOCLONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY GOAT POLYCLONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY GOAT POLYCLONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY RABBIT POLYCLONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY RABBIT POLYCLONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY AGAROSE BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY AGAROSE BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PARAMAGNETIC BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PARAMAGNETIC BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY SUPERPARAMAGNETIC BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY SUPERPARAMAGNETIC BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY EPIGENETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY POST TRANSLATIONAL MODIFICATION STUDY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY POST TRANSLATIONAL MODIFICATION STUDY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PROTEIN ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PROTEIN ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 88. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 89. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 90. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 91. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 92. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 93. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 96. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 97. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 102. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 103. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 104. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 105. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 106. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 107. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 174. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 175. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 176. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 177. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 178. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 179. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 188. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 189. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 190. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 191. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 192. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 193. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 216. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 217. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 218. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 219. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 220. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 221. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 224. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 225. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 230. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 231. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 232. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 233. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 234. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 235. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 286. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 287. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 288. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 289. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 290. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 291. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 314. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 315. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 316. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 317. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 318. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 319. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TABLE 322. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2030 (USD MILLION)
TABLE 323. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2018-2024 (USD MILLION)
TABLE 328. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY ANTIBODY, 2025-2030 (USD MILLION)
TABLE 329. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 330. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 331. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 332. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 333. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Abcam plc
  • Bio-Techne Corporation
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • GenScript Biotech Corporation

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.14 Billion
Compound Annual Growth Rate20.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Immunoprecipitation Market Size, Share and Trends Analysis Report by Product (Kits, Reagents), Type, End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), and Region 2024-2030 - Product Image

Immunoprecipitation Market Size, Share and Trends Analysis Report by Product (Kits, Reagents), Type, End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Immunoprecipitation - Global Strategic Business Report - Product Image

Immunoprecipitation - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Chromatin Immunoprecipitation (ChIP) Sequencing Market Report 2025 - Product Image

Chromatin Immunoprecipitation (ChIP) Sequencing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast 2025-2030 - Product Image

Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Gel Filtration Chromatography Market by Product Type (Membrane, Traditional), End Use (Academic, Biotechnology, Food), Application, Column Size - Global Forecast 2025-2030 - Product Image

Gel Filtration Chromatography Market by Product Type (Membrane, Traditional), End Use (Academic, Biotechnology, Food), Application, Column Size - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.